← Back to Search

Group Wellness Interventions for Neurologic Conditions

N/A

Recruiting

Research Sponsored by Kessler Foundation

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Must not have

For Individuals with Alzheimer's Disease Related Dementias (ADRD): has had a prior stroke or neurological disease other than ADRD, has unstable or uncontrolled seizures, has been hospitalized due to a significant psychiatric illness (e.g. bipolar disorder, schizophrenia, or psychosis) in the past three months, current alcohol and/or drug use that interferes with ability to carry out common everyday functions

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 12 weeks (between pre- and post-testing) and 6 months (between post-testing and 6 month follow-up)

Awards & highlights

No Placebo-Only Group

Summary

This trialwill look at how two types of group wellness treatments can help those with TBI or dementia and their loved ones.

Who is the study for?

This trial is for adults aged 18-64 with mild or severe TBI at least a few months post-injury, and those 65+ with ADRD at least one year post-diagnosis. Participants must speak English fluently and have a support person willing to join the study. Excluded are individuals with significant neurological history other than their condition, uncontrolled seizures, recent psychiatric hospitalization, or substance abuse affecting daily functions.

What is being tested?

The study compares two group wellness programs designed for people living with chronic mild to severe traumatic brain injuries (TBI) or Alzheimer's disease-related dementias (ADRD), along with their support persons. The goal is to evaluate which program better promotes long-term wellness in these populations.

What are the potential side effects?

Since this trial involves non-medical interventions like wellness classes rather than drugs or medical procedures, traditional side effects are not expected. However, participants may experience emotional discomfort or fatigue related to discussing personal experiences during sessions.

Eligibility Criteria

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I have Alzheimer's or related dementia without recent severe psychiatric issues, uncontrolled seizures, or substance misuse.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 12 weeks (between pre- and post-testing) and 6 months (between post-testing and 6 month follow-up)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~12 weeks (between pre- and post-testing) and 6 months (between post-testing and 6 month follow-up)

This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 weeks (between pre- and post-testing) and 6 months (between post-testing and 6 month follow-up) for reporting.